Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis

Rheumatology International

Volumn 35, Issue 5, 2015, Pages 905-909

  Ungprasert, Patompong ^a   Cheungpasitporn, Wisit ^a   Wijarnpreecha, Karn ^b   Ahuja, Wasin ^b   Ratanasrimetha, Praveen ^c   Thongprayoon, Charat ^a  

^a MAYO CLINIC   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dermatomyositis; Idiopathic inflammatory myositis; Ischemic stroke; Meta analysis; Polymyositis

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; DERMATOMYOSITIS; DISEASE ASSESSMENT; DISEASE PREDISPOSITION; HAZARD RATIO; HUMAN; OBSERVATIONAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; SYSTEMATIC REVIEW; COMPLICATION; META ANALYSIS; STROKE;

BRAIN ISCHEMIA; DERMATOMYOSITIS; HUMANS; POLYMYOSITIS; RISK FACTORS; STROKE;

EID: 84928818317     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3166-0     Document Type: Article

References (26)

1. Frostegard J (2005) Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 25:1776–1785
2. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874
3. Montecucco F, Mach F (2009) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 48:11–22
4. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabreil SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732
5. Bessant R, Hingorani A, Patel L et al (2004) Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 43:924–929
6. Timlin H, Petri M (2013) Transient ischemic attack and stroke is systemic lupus erythematosus. Lupus 22:1251–1258
7. Iaccarino L, Ghirardello A, Bettio S et al (2014) The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 48–49:122–127
8. Ungprasert P, Suksaranjit P, Spanuchart I et al (2014) Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 44:63–67
9. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188
11. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
12. Tisseverasinghe A, Bernatsky S, Pineau CA (2009) Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 36:1943–1946
13. Zoller B, Li X, Sundquist J, Sunquist K (2012) Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 12:41
14. Lai YT, Dai YS, Yen MF et al (2013) Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow up study. Br J Dermatol 168:1054–1059
15. Krishnan E (2005) Stroke subtypes among young patients with systemic erythematosus. Am J Med 118:1415.e1–1415.e7
16. Lindhardsen J, Ahlehoff O, Gislason GH et al (2012) Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 344:e1257
17. Lin CW, Huang YP, Chiu YH et al (2014) Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population based longitudinal follow-up study. PLoS One 9:e94027
18. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695
19. Xu J, Lupu F, Esmon CT (2010) Inflammation, innate immunity and blood coagulation. Hamostaseologie 30(5–6):8–9
20. Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131:417–430
21. de Moraes MT, de Souza FH, de Barros TB et al (2013) Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res (Hoboken) 65:793–799
22. Limaye VS, Lester S, Blumbergs P et al (2010) Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis 13:132–137
23. Wei L, MacDonald TM, Walker BR (2004) Taking glucocorticoid by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764–770
24. Maradit-Kremers H, Reinalda MS et al (2007) Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatic. Arthritis Rheum 57:279–286
25. Toms TE, Panoulas VF, Douglas KM et al (2008) Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 10:R145
26. Voisard R, Seitzer U, Baur R, Dartsch PC, Osterhues H et al (1994) Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. Int J Cardiol 43:257–267